McAdam LLC’s STAAR Surgical STAA Stock Holding History

McAdam LLC’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-34	Closed	-$1K	–	793
2018 Q1	$1K	Buy	+34	New	+$531	﹤0.01%	696

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

McAdam LLC's STAA Position: Q2 2018 in Review

McAdam LLC sold out of STAAR Surgical (STAA) in Q2 2018, closing a stake of 34 shares — an estimated $1K sold.

McAdam LLC first reported a position in STAA in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 151 funds tracked by Wall St. Rank hold STAA as of Q2 2018.

McAdam LLC reported no remaining STAAR Surgical position as of Q2 2018 after selling out during the quarter.
McAdam LLC sold 34 STAAR Surgical shares in Q2 2018, an estimated $1K.
McAdam LLC first reported a position in STAAR Surgical in Q1 2018 and held it in 1 quarter.
McAdam LLC's STAAR Surgical position peaked at $1K in Q1 2018.
151 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.